4.7 Article

Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis

期刊

RHEUMATOLOGY
卷 56, 期 9, 页码 1579-1585

出版社

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kex239

关键词

rheumatoid arthritis; epidemiology; reproductive; biomarkers; autoantibodies; anticitrullinated protein antibodies; risk factors; women

资金

  1. Fonds National Suisse de la Recherche Scientifique [3200B0_120639/1-AF]

向作者/读者索取更多资源

Objectives. To analyse the association between female hormonal factors and the development of systemic autoimmunity associated with RA in women at increased risk for RA, namely first-degree relatives of patients with RA (RA-FDRs). Methods. In an ongoing cohort study of RA-FDRs, we analysed all women with available ACPA status. The primary outcome was ACPA positivity. The predictors of interest were female hormonal factors, such as oral contraceptives, breastfeeding, post-menopausal status, early post-menopausal period and total number of ovulatory years. Results. A total of 768 female RA-FDRs were analysed, of which 42 (5%) had developed ACPA positivity. ACPA-positive women were older (52 vs 44 years, P = 0.001). Hormonal factors significantly and independently associated with the presence of ACPA were the post-menopausal (P < 0.001) and the early postmenopausal periods (P = 0.040). Conclusions. In women at increased risk of RA, characteristic systemic autoimmunity was associated with menopause, suggesting that the acute decline in ovarian function might contribute to the development of autoimmunity associated with RA and potentially to the increased risk of RA in women.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Rheumatology

Response to: 'Correspondence on 'Prevotella copri in individuals at risk for rheumatoid arthritis'' by Sun and Ni

Benoit Thomas P. Gilbert, Axel Finckh, Deshire Alpizar Rodriguez

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Sport Sciences

Heart rate recovery to assess fitness: comparison of different calculation methods in a large cross-sectional study

Denis Mongin, Clovis Chabert, Delphine Sophie Courvoisier, Jeronimo Garcia-Romero, Jose Ramon Alvero-Cruz

Summary: This study proposes a cross-sectional study based on 980 maximal effort tests to investigate the effect of heart rate recovery (HRR) calculation methods on its association with cardiorespiratory fitness (CRF). The results show that there is no significant association between HRR indices based on exponential regression and CRF. However, other HRR indices are associated with CRF when t(0) is at least 1 minute, with the strongest association observed at t(0) = 2 minutes for females and t(0) = 3 minutes for males.

RESEARCH IN SPORTS MEDICINE (2023)

Review Rheumatology

A Mixed-Methods Systematic Review on Syndemics in Rheumatology

Maria F. Ramirez-Flores, Cinthya Cadena-Trejo, Emilio Motte-Garcia, Isaac D. Juarez-Cruz, Maria V. Fernandez-Garcia, Alfonso Gastelum-Strozzi, Deshire Alpizar-Rodriguez, Adolfo Hernandez-Garduno, Ingris Pelaez-Ballestas

Summary: A syndemic framework is used to assess the multidimensionality of diseases and their circumstances, providing important insights in various fields. This study aimed to evaluate the use of this framework in rheumatic and musculoskeletal diseases (RMDs). The results showed limited application of syndemic studies in rheumatology, highlighting the need for further research.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2023)

Correction Rheumatology

Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations (Vol 50, pg 119, 2023)

Ying-Ying Leung, Tatiana Korotaeva, Liliana Candia, Susanne Juhl Pedersen, Wilson Bautista Molano, Eric M. Ruderman, Radjesh Bisoendial, Rodolfo Perez-Alamino, Wendy Olsder, Burkhard Moller, Simeon Grazio, Tania Gudu, Girish M. Mody, Carlos Pineda, Helena Raffayova, Sherry Rohekar, Claudia Goldenstein-Schainberg, Sergio R. Gutierrez Urena, Julio Cesar Casasola Vargas, Bhowmik Meghnathi, Roopa Prasad, Pascal Richette, Jose Roberto S. Miranda, Nikolas Malliotis, Ulla Lind-Qvist, David Simon, Amara Ezeonyeji, Enrique R. Soriano, Oliver FitzGerald

JOURNAL OF RHEUMATOLOGY (2023)

Editorial Material Rheumatology

Back Pain from the Perspectives of General Practitioners, Rheumatology and orthopedic Surgery

Burkhard Moeller, Joachim Grifka

ZEITSCHRIFT FUR RHEUMATOLOGIE (2023)

Article Rheumatology

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

Louise Linde, Lykke M. Ornbjerg, Stylianos Georgiadis, Simon H. Rasmussen, Ulf Lindstrom, Johan Askling, Brigitte Michelsen, Daniela Di Giuseppe, Johan K. Wallman, Bjorn Gudbjornsson, Thorvardur Jon Love, Dan C. Nordstrom, Timo Yli-Kerttula, Lucie Nekvindova, Jiri Vencovsky, Florenzo Iannone, Alberto Cauli, Anne Gitte Loft, Bente Glintborg, Karin Laas, Ziga Rotar, Matija Tomsic, Gary J. Macfarlane, Burkhard Moller, Marleen van de Sande, Catalin Codreanu, Michael J. Nissen, Merih Birlik, Sukran Erten, Maria J. Santos, Elsa Vieira-Sousa, Merete L. Hetland, Mikkel Ostergaard

Summary: In bio-naive patients with PsA initiating a TNF inhibitor (TNFi), baseline predictors of Disease Activity index for PsA in 28 joints (DAPSA28) remission and moderate response at 6 months, as well as drug retention at 12 months were identified, indicating potential generalizability from country to disease level.

RHEUMATOLOGY (2023)

Article Health Care Sciences & Services

Effectiveness of a Mobile App (PIMPmyHospital) in Reducing Therapeutic Turnaround Times in an Emergency Department: Protocol for a Pre- and Posttest Study

Frederic Ehrler, Carlotta Tuor, Robin Rey, Remy Trompier, Antoine Berger, Michael Ramusi, Delphine S. Courvoisier, Johan N. Siebert

Summary: This study aims to explore the impact of a mobile app called PIMPmyHospital on the timeliness of accessing laboratory results in emergency departments (EDs), as well as its effectiveness on ED length of stay, technology acceptance, and usability. The study will be conducted in a pediatric ED in Switzerland, with participants including postgraduate residents, pediatric emergency medicine fellows, and registered nurses. The results of the study are expected to be published in a peer-reviewed journal in late 2023.

JMIR RESEARCH PROTOCOLS (2023)

Article Rheumatology

Distribution and characteristics of the certification of rheumatologists in Mexico

Everardo Alvarez-Hernandez, Eduardo Barreira-Mercado, Hilda E. Fragoso-Loyo, Cristina Hernandez-Diaz, Blanca Mota-Mondragon, Sandra Munoz-Lopez, Mario Perez-Cristobal, Nadina Rubio-Perez, Alfonso Torres-Jimenez, Angelica Vargas Guerrero, Monica Vazquez del Mercado, Miguel Angel Villarreal-Alarcon, Cesar Pacheco-Tena, Deshire Alpizar-Rodriguez

Summary: The study aims to describe the distribution of adult and pediatric rheumatologists in Mexico and the factors associated with this distribution. The databases of the Mexican Council of Rheumatology and the Mexican College of Rheumatology for 2020 were reviewed to analyze the number, age, and gender of certified rheumatologists by state. The results show a shortage of rheumatologists in Mexico, with underserved regions in the pediatric area. It is important to implement health policies to achieve a more balanced and efficient regionalization of this specialty and increase the percentage of certified rheumatologists.

REUMATOLOGIA CLINICA (2023)

Article Immunology

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases

Axel Finckh, Adrian Ciurea, Catherine E. Raptis, Andrea Rubbert-Roth

Summary: Immune-mediated inflammatory diseases (IMIDs) are a diverse group of diseases characterized by immune dysregulation, such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. The prevalence of IMIDs ranges between 5% and 7% in developed countries. The use of immunomodulatory medications in the management of IMIDs can weaken the immune response and increase the risk of severe outcomes from COVID-19, as well as reduce the efficacy of COVID-19 vaccination. This article summarizes the current literature on COVID-19 outcomes, vaccination responses, and the impact of immunomodulatory therapies in patients with rheumatologically dominated IMIDs, and provides vaccination recommendations for individuals with IMID.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Rheumatology

Biologic disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts

Burkhard Moller, Godehard A. Scholz, Jennifer Amsler, Adrian Ciurea, Raphael Micheroli, Michael J. Nissen, Eleftherios Papagiannoulis, Christoph Blapp, Almut Scherer, Nikhil Yawalkar

Summary: This study compared the effectiveness of the first biologic DMARD (bDMARD) in patients with low and high joint counts. The results showed that bDMARD had similar drug retention rates in patients with low and high joint counts. Furthermore, bDMARD retention was significantly better when administered with conventional synthetic DMARD co-therapy.

RHEUMATOLOGY (2023)

Article Rheumatology

Time to Publication and Time-Lag Publication Bias for Randomized Trials on Connective Tissue Diseases

Denis Mongin, Barbara Russo, Alejandro Brigante, Sami Capderou, Delphine S. Courvoisier, Michele Iudici

Summary: This study aimed to assess the time from completion to publication of randomized controlled trials (RCTs) on connective tissue diseases (CTDs) and investigate the factors associated with the time to publication. The results showed that a high proportion of CTDs-RCTs were published beyond 2 years from completion. The time to publication improved over time and was not influenced by the significance of primary outcome results, funder, impact factor of the journal, number of recruiting countries, and comparator.

ACR OPEN RHEUMATOLOGY (2023)

Article Health Care Sciences & Services

Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study

Maria-Eugenia Zaballa, Javier Perez-Saez, Carlos de Mestral, Nick Pullen, Julien Lamour, Priscilla Turelli, Charlene Raclot, Helene Baysson, Francesco Pennacchio, Jennifer Villers, Julien Duc, Viviane Richard, Roxane Dumont, Claire Semaani, Andrea Jutta Loizeau, Clement Graindorge, Elsa Lorthe, Jean-Francois Balavoine, Didier Pittet, Manuel Schibler, Nicolas Vuilleumier, Francois Chappuis, Omar Kherad, Andrew S. Azman, Klara M. Posfay-Barbe, Laurent Kaiser, Didier Trono, Silvia Stringhini, Idris Guessous

Summary: In Geneva, Switzerland, over 93.8% of the population has developed anti-SARS-CoV-2 antibodies, with 72.4% acquired through infection. However, there is lower neutralization capacity against the Omicron BA.5 subvariant, especially in children under 12 years old. Additional booster doses after vaccination and infection can enhance neutralization capacity.

LANCET REGIONAL HEALTH-EUROPE (2023)

Article Rheumatology

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

Pedro M. Machado, Martin Schaefer, Satveer K. Mahil, Jean Liew, Laure Gossec, Nick Dand, Alexander Pfeil, Anja Strangfeld, Anne Constanze Regierer, Bruno Fautrel, Carla Gimena Alonso, Carla G. S. Saad, Christopher E. M. Griffiths, Claudia Lomater, Corinne Miceli-Richard, Daniel Wendling, Deshire Alpizar Rodriguez, Dieter Wiek, Elsa F. Mateus, Emily Sirotich, Enrique R. Soriano, Francinne Machado Ribeiro, Felipe Omura, Frederico Rajao Martins, Helena Santos, Jonathan Dau, Jonathan N. Barker, Jonathan Hausmann, Kimme L. Hyrich, Lianne Gensler, Ligia Silva, Lindsay Jacobsohn, Loreto Carmona, Marcelo M. Pinheiro, Marcos David Zelaya, Maria de los Angeles Severina, Mark Yates, Maureen Dubreuil, Monique Gore-Massy, Nicoletta Romeo, Nigil Haroon, Paul Sufka, Rebecca Grainger, Rebecca Hasseli, Saskia Lawson-Tovey, Suleman Bhana, Thao Pham, Tor Olofsson, Wilson Bautista-Molano, Zachary S. Wallace, Zenas Z. N. Yiu, Jinoos Yazdany, Philip C. Robinson, Catherine H. Smith

Summary: This study investigated factors associated with severe COVID-19 in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis. The study found that age, sex, comorbidities, disease activity, and glucocorticoid use were associated with the severity of COVID-19. Additionally, later pandemic time periods, psoriasis, and the use of TNFi, IL17i, and IL-23i/IL-12+23i were associated with a reduced risk of severe COVID-19.

ANNALS OF THE RHEUMATIC DISEASES (2023)

暂无数据